Platelet function and thrombin activity in patients with recent cerebral transient ischemic attacks.

Area of Science:

• Neurology
• Hematology
• Vascular Biology

Background:

• Transient ischemic attacks (TIAs) are warning signs for stroke.
• The underlying pathophysiology of TIAs, particularly the role of hemostasis, requires further elucidation.
• Atherosclerosis is a common cause of TIAs, but other mechanisms may be involved.

Purpose of the Study:

• To investigate platelet function and thrombin activity in patients following transient ischemic attacks.
• To determine if hypercoagulable states persist after the acute phase of TIAs.
• To explore the potential pathogenetic role of the hemostatic system in TIAs.

Main Methods:

• Studied 12 patients with recent TIAs and 12 matched controls.
• Excluded significant atherosclerotic disease through comprehensive clinical and instrumental evaluations (Doppler sonography, angiography, CT scan).
• Assessed collagen-induced platelet thromboxane B2 production, plasma beta-thromboglobulin, and fibrinopeptide A levels.

Main Results:

• Patients with TIAs exhibited significantly higher levels of platelet thromboxane B2, plasma beta-thromboglobulin, and fibrinopeptide A compared to controls.
• Platelet aggregation induced by collagen was comparable between patients and controls.
• Elevated markers indicate increased platelet activation and thrombin generation in TIA patients.

Conclusions:

• Platelet hyperfunction and enhanced thrombin activity are present in patients weeks after a transient ischemic attack.
• These findings suggest a primary pathogenetic role for the hemostatic system in the development of TIAs.
• The hemostatic system may be a therapeutic target for preventing recurrent ischemic events.